共 50 条
- [21] ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation statusEUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) : 361 - 362Hamalainen, MauriJuvonen, VesaHaikio, SatuLakkala, TainaJohansson, JanitaPelliniemi, Tarja-TerttuSalmi, Toivo T.Remes, KariKairisto, Veli
- [22] Prognostic Significance Of NPM1 mutations In The Absence Of FLT3-ITD in Older Patients With AML: A SWOG ReportBLOOD, 2013, 122 (21)Ostronoff, FabianaOthus, MeganMeshinchi, SoheilGodwin, John E.Kopecky, Kenneth J.List, AlanOehler, Vivian G.Petersdorf, StephenPogosova-Agadjanyan, Era L.Radich, JeraldWillman, Cheryl L.Appelbaum, Frederick R.Stirewalt, Derek L.
- [23] ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotypeCANCER MEDICINE, 2020, 9 (11): : 3637 - 3646Prats-Martin, ConcepcionBurillo-Sanz, SergioMorales-Camacho, Rosario M.Perez-Lopez, OlgaSuito, MilagrosVargas, Maria T.Caballero-Velazquez, TeresaCarrillo-Cruz, EstrellaGonzalez, JoseBernal, RicardoPerez-Simon, Jose A.
- [24] Acquisition of a BCR-ABL1 Transcript in a Patient with Disease Progression from MDS with Fibrosis to AML with Myelodysplasia-Related ChangesANNALS OF CLINICAL AND LABORATORY SCIENCE, 2011, 41 (04): : 379 - 384Park, Seo-JinLee, Hyun WooJeong, Seong HyunPark, Joon SeongKim, Hugh ChulSeok, Jae YeonKim, Hyon J.Cho, Sung Ran
- [25] The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based settingBLOOD ADVANCES, 2020, 4 (06) : 1094 - 1101Juliusson, GunnarJadersten, MartinDeneberg, StefanLehmann, SorenMollgard, LarsWennstrom, LovisaAntunovic, PetarCammenga, JorgLorenz, FryderykOlander, EmmaLazarevic, Vladimir LjHoglund, Martin
- [26] Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AMLBLOOD, 2009, 114 (11) : 2220 - 2231Schnittger, SusanneKern, WolfgangTschulik, ClaudiaWeiss, TamaraDicker, FrankFalini, BrunangeloHaferlach, ClaudiaHaferlach, Torsten
- [27] Frequency, Clinical Associations, and Prognostic Significance Of Spliceosome Mutations In Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes and Therapy-Related Acute Myeloid LeukemiaBLOOD, 2013, 122 (21)Cho, Young-UkChi, Hyun-SookPark, Sang HyukKim, Young JinJang, SeongsooSeo, Eul-JuPark, Chan-JeoungKim, Dae-YoungLee, Jung-HeeLee, Je-HwanLee, Kyoo-HyungKoh, Kyung NamIm, Ho JoonSeo, Jong JinPark, Young-MiLee, Jong-Keuk
- [28] Minimal Residual Disease Assessed by NPM1 Mutation Specific RQ-PCR Is the Most Relevant Prognostic Parameter in NPM1-Mutated AML and Highly Useful to Guide TherapyBLOOD, 2008, 112 (11) : 260 - 260Schnnittger, SusanneKern, WolfgangWeiss, TamaraTschulik, ClaudiaDicker, FrankHaferlach, ClaudiaHaferlach, Torsten
- [29] The Presence of Multilineage Dysplasia (MLD) Has No Significant Impact On Biological, Clinico-Pathological, and Prognostic Features in AML with Mutated Nucleophosmin (NPM1).BLOOD, 2009, 114 (22) : 1027 - 1027Haferlach, TorstenMacijewski, KatjaWeiss, TamaraBacher, UlrikeSchnittger, SusanneKern, WolfgangKohlmann, AlexanderKlein, Hans-UlrichVignetti, MarcoPiciocchi, AlfonsoFazi, PaolaMartelli, Maria PaolaPileri, Stefano AldoMiesner, MiriamSantucci, AntonellaMarafioti, TeresaHaferlach, ClaudiaMandelli, FrancoFalini, Brunangelo
- [30] Prognostic significance of NPM1, CEBPA, and MLL-PTDs mutations, EVI1, MN1 and ERG expressions in MDS and AML treated with azacitidineLEUKEMIA RESEARCH, 2013, 37 : S70 - S71Jonasova, A.Kostecka, A.Vostry, M.Neuwirtova, R.Fuchs, O.